Supplementary_Appendix.docx (104.77 kB)

Sintilimab plus chemotherapy for first-line treatment of advanced or metastatic nonsquamous non-small-cell lung cancer: network meta-analysis. Supplementary Appendix

dataset

posted on 2023-02-07, 09:37 authored by George R Blumenschein, Saman Souri, Jing Voon Chen, Kristi Gruver, Mark A Belger, Victoria J Stefaniak, Alan Brnabic, Cliff Molife

Supplementary appendix

History

Usage metrics

Keywords

intilimab non-small-cell lung cancers non-squamous network meta-analysis immunotherapy anti-PD-L1 anti-PD-1

Licence

CC BY-NC-ND 4.0

Sintilimab plus chemotherapy for first-line treatment of advanced or metastatic nonsquamous non-small-cell lung cancer: network meta-analysis. Supplementary Appendix

History

Usage metrics

Categories

Keywords

Licence

Exports